IRCCS Ospedale Galeazzi- Sant’Ambrogio provides specialized Larynx Cancer Treatment with an emphasis on accurate tumor staging, evidence-based treatment selection, and comprehensive follow-up care. Established in 1963, the SSN accredited hospital is based in milan, Italy and has 560 beds supported by advanced ENT, surgical oncology, and radiation therapy facilities.

Larynx Cancer Treatment is planned after confirming the diagnosis and determining the cancer's location, stage, and biological characteristics. Depending on the individual case, treatment may include radiation, chemotherapy, targeted medicines, immunotherapy, or surgery to remove part or all of the larynx. The treatment team also considers the potential impact on speech, swallowing, and breathing. Follow-up care includes surveillance for recurrence and rehabilitation to support communication, nutrition, and daily functioning.